Identification of high‐dimensional omics‐derived predictors for tumor growth dynamics using machine learning and pharmacometric modeling
Abstract Pharmacometric modeling can capture tumor growth inhibition (TGI) dynamics and variability. These approaches do not usually consider covariates in high‐dimensional settings, whereas high‐dimensional molecular profiling technologies (“omics”) are being increasingly considered for prediction...
Main Authors: | Laura B. Zwep, Kevin L. W. Duisters, Martijn Jansen, Tingjie Guo, Jacqueline J. Meulman, Parth J. Upadhyay, J. G. Coen vanHasselt |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-04-01
|
Series: | CPT: Pharmacometrics & Systems Pharmacology |
Online Access: | https://doi.org/10.1002/psp4.12603 |
Similar Items
-
The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometrics.
by: van Hasselt, J, et al.
Published: (2012) -
Metaheuristics for pharmacometrics
by: Seongho Kim, et al.
Published: (2021-11-01) -
Pharmacometrics and/or Systems Pharmacology
by: Piet H. van derGraaf
Published: (2019-06-01) -
Adoption of Machine Learning in Pharmacometrics: An Overview of Recent Implementations and Their Considerations
by: Alexander Janssen, et al.
Published: (2022-08-01) -
Evaluation of machine learning methods for covariate data imputation in pharmacometrics
by: Dominic Stefan Bräm, et al.
Published: (2022-12-01)